Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" to cast your ballot, or contact membership@iaslc.org

ESMO 2023 Highlights: Early-Stage NSCLC, SCLC, Thymic Carcinoma

Episode
183
Soundcloud
Share

Part 2 of our podcast coverage on ESMO 2023 includes an in-depth interview with Dr. Jarushka Naidoo on early-stage NSCLC, including updates from CHECKMATE 816, KEYNOTE 671 overall survival results, and Checkmate77T, first perceptions about the data, remaining unanswered questions and how to incorporate to our clinical practice. Further, we discussed exciting data in the 2nd line setting for Small-Cell Lung Cancer and a new potential therapeutic option for thymic carcinoma. Tune in for this thought-provoking, data-driven, and practical episode of Lung Cancer Considered.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Jarushka Naidoo
Jarushka Naidoo

MD

Medical Oncologist
Beaumont Hospital

Other Podcast

LALCA 2024 Highlights
Episode
263
Lung Cancer Considered 2024 in Review
Episode
262